Nathan J. Cherrington
- Epidemiology top 5%
- Oncology top 5%
- Molecular Biology
- Pharmacology top 1%
- Hepatology top 5%
- Co-authors
- Craig D. FisherAndrew J. LickteigLisa M. AugustineMatthew D. MerrellCurtis D. KlaassenAngela L. SlittJonathan P. JacksonDylan P. Hartley
- Topics
- Liver Disease Diagnosis and Treatment (19 papers)Drug Transport and Resistance Mechanisms (17 papers)Pharmacogenetics and Drug Metabolism (10 papers)
- Cited by
- PharmacologyHepatologyOncology
- Partner nations
- United StatesJapanCanada
In The Last Decade
Nathan J. Cherrington
34 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 96
- Epidemiology 596
- Oncology 504
- Molecular Biology 379
- Pharmacology 362
- Hepatology 197
Countries citing papers authored by Nathan J. Cherrington
This map shows the geographic impact of Nathan J. Cherrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan J. Cherrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan J. Cherrington more than expected).
Fields of papers citing papers by Nathan J. Cherrington
This network shows the impact of papers produced by Nathan J. Cherrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan J. Cherrington. The network helps show where Nathan J. Cherrington may publish in the future.
Co-authorship network of co-authors of Nathan J. Cherrington
This figure shows the co-authorship network connecting the top 25 collaborators of Nathan J. Cherrington. A scholar is included among the top collaborators of Nathan J. Cherrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan J. Cherrington. Nathan J. Cherrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 9 | |
| 4 | 5 | |
| 5 | 10 | |
| 6 | 29 | |
| 7 | 22 | |
| 8 | 11 | |
| 9 | 12 | |
| 10 | 44 | |
| 11 | 36 | |
| 12 | 131 | |
| 13 | 1 | |
| 14 | 91 | |
| 15 | 268 | |
| 16 | 45 | |
| 17 | 83 | |
| 18 | 56 | |
| 19 | 128 | |
| 20 | 32 |
About Nathan J. Cherrington
Nathan J. Cherrington is a scholar working on Pharmacology, Hepatology and Oncology, having authored 35 papers that have together received 1.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (19 papers), Drug Transport and Resistance Mechanisms (17 papers) and Pharmacogenetics and Drug Metabolism (10 papers). The work is most often cited by research in Pharmacology (362 citations), Hepatology (197 citations) and Oncology (504 citations). Nathan J. Cherrington has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine, Matthew D. Merrell, Curtis D. Klaassen, Angela L. Slitt, Jonathan P. Jackson, Dylan P. Hartley, Stephen Ferguson and James Ranger‐Moore. Their work appears in journals such as Journal of Biological Chemistry, Gastroenterology and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.